Australia markets close in 6 hours 9 minutes
  • ALL ORDS

    7,656.60
    -79.20 (-1.02%)
     
  • ASX 200

    7,332.50
    -76.30 (-1.03%)
     
  • AUD/USD

    0.7211
    +0.0026 (+0.36%)
     
  • OIL

    86.17
    -0.79 (-0.91%)
     
  • GOLD

    1,840.70
    +28.30 (+1.56%)
     
  • BTC-AUD

    58,214.57
    -1,059.66 (-1.79%)
     
  • CMC Crypto 200

    992.24
    -2.50 (-0.25%)
     
  • AUD/EUR

    0.6355
    +0.0016 (+0.25%)
     
  • AUD/NZD

    1.0629
    +0.0021 (+0.20%)
     
  • NZX 50

    12,609.33
    -2.98 (-0.02%)
     
  • NASDAQ

    15,047.84
    -162.92 (-1.07%)
     
  • FTSE

    7,589.66
    +26.11 (+0.35%)
     
  • Dow Jones

    35,028.65
    -339.82 (-0.96%)
     
  • DAX

    15,809.72
    +37.16 (+0.24%)
     
  • Hang Seng

    24,127.85
    +15.07 (+0.06%)
     
  • NIKKEI 225

    27,467.23
    -790.02 (-2.80%)
     

IQVIA Decentralized Trial Suite Launches Mobile Research Nursing and Phlebotomy Services Unit

  • Oops!
    Something went wrong.
    Please try again later.
·3-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

RESEARCH TRIANGLE PARK, N.C., December 02, 2021--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, is launching new Research Nursing and Phlebotomy services. These new services offer patients participating in clinical trials access to a global network of high-quality, credentialed professionals that provide compassionate protocol-required care within their own homes.

"We believe combining clinical research and patient care produces better patient outcomes, reduces cost of care, and advances research that will benefit patients," said Ronan Brown, global head of IQVIA Decentralized Trial Solutions. "This is another example of IQVIA’s continued investment in patient centric research experiences to demonstrate to participants that their health needs are the top priority of sponsors."

IQVIA Research Nursing and Phlebotomy teams can perform a variety of assessments, as well as data and specimen collection. They also support direct-to-patient delivery and administration of investigational products. Available as a stand-alone service or as part of a broader decentralized clinical trial solution, our in-house network of highly skilled healthcare professionals simplifies trial delivery, benefiting sponsors, sites, and patients. By deploying experienced mobile research teams in clinical trials, IQVIA believes it can enhance the patient experience, strengthen retention, and drive efficiency by improving protocol compliance and expanding the trial’s geographic reach.

"We’re pushing the boundaries of what’s possible by delivering a flexible, reliable mobile workforce with the adaptability and scale to meet any sponsor’s requirements – small or large, local or global," said Brown.

By adding this capability to our decentralized clinical trials offering, IQVIA can deliver nearly every component of a decentralized clinical trial, creating an even more seamless solution. Furthermore, IQVIA backs our mobile study teams with training and quality oversight, ensuring quality and driving efficiency from the first patient into the last patient out.

Learn more at https://www.iqvia.com/solutions/research-and-development/decentralized-trials/research-nursing-and-phlebotomy-solutions.

About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 77,000 employees, IQVIA conducts operations in more than 100 countries.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211202005218/en/

Contacts

Nick Childs, IQVIA Investor Relations (nick.childs@iqvia.com)
+1.973.316.3828

Tor Constantino, IQVIA Media Relations (tor.constantino@iqvia.com)
+1.484.567.6732

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting